Physicians' payment ties in with performance

Article

A movement in Congress would link any change in Medicare payments to new requirements to improve quality of care.

A movement in Congress would link any change in Medicare payments to new requirements to improve quality of care.

In testimony before Congress, Dr. Mark McClellan, administrator of the Centers for Medicare and Medicaid Services, said that linking payments to valid measures of quality would give physicians more direct incentives to implement approaches that result in improvements in care (NEJM 2005; 353:870-872).

McClellan outlined several initiatives the CMS has identified for this effort. One is to develop, in conjunction with the American Medical Association, quality measures of ambulatory care that will test pay-for-performance approaches.

The CMS also plans to use Medicare claims data to measure physician resources and confidentially share the results with physicians to educate them, according to the New England Journal of Medicine report.

All of this jockeying is aimed at avoiding the nearly 4.3% cut in the Medicare fee-for-service payments to physicians scheduled to take effect Jan. 1. Whether the government can tweak the formula known as the sustainable growth rate without dismantling the new prescription drug benefit to find money for physicians remains to be seen. But as the report noted, the search for compromise is already under way.

Recent Videos
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Related Content
© 2025 MJH Life Sciences

All rights reserved.